FDA forms advisory committee to regulate digital health
Grandbrothers

The U.S. Food and Drug Administration (FDA) established a new Digital Health Advisory Committee on Wednesday to help it in making decisions related to digital health technologies (DHTs) such as digital therapeutics and wearables.
The agency added that nine voting members, led by a chairperson, will make up the inaugural Digital Health Advisory Committee, which will be fully operational next year.

The FDA said it will seek the panelist's views to ensure digital health devices meet the needs of diverse populations.
iShares U.S. Medical Devices ETF (NYSEARCA:IHI) fell ~5%, marking the biggest intraday decline in more than a year following the announcement.
Dominant players in the MedTech industry, including DexCom (DXCM), Intuitive Surgical (ISRG), Stryker Corporation (SYK), ResMed (RMD), Medtronic (MDT), and Abbott Laboratories (ABT), are among notable decliners.
"Many of these technologies are novel and tend to rapidly change; it's our duty to seek as much knowledge on them as possible as we determine and implement appropriate regulation to encourage innovation while protecting public health," the director of the FDA's Center of Excellence for Digital Health said.


More on iShares U.S. Medical Devices ETF

IHI: Too Expensive Considering Long-Term Rate Uncertainty
JPMorgan says time to buy MedTech based on past
Seeking Alphaâs Quant Rating on iShares U.S. Medical Devices ETF
Dividend scorecard for iShares U.S. Medical Devices ETF